clinical efficacy of oral administration of metronidazole in the treatment of primary sclerosing cholangitis
Not Applicable
- Conditions
- primary sclerosing cholangitis
- Registration Number
- JPRN-UMIN000021411
- Lead Sponsor
- Keio University, School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with a decompensated cirrhosis (Child Pugh score upper 10 point)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serological improvement in the hepatobiliary function (serum ALP and total bilirubin) at 12weeks after the treatment
- Secondary Outcome Measures
Name Time Method Alteration of the intestinal flora during the treatment